We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

14 hedge funds and large institutions have $1.09M invested in NeuroMetrix, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

36% more capital invested

Capital invested by funds: $799K → $1.09M (+$288K)

27% more funds holding

Funds holding: 1114 (+3)

Holders
14
Holders Change
+3
Holders Change %
+27.27%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
2
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

NURO Hedge Fund Activity: Q1 2019 in Review

14 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q1 2019, worth a combined $1.09M — up 36% from $799K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new NURO positions and 2 closed out — a net gain of 3 holders — while 2 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $86.6K. The largest seller was Sabby Management, cutting an estimated $370K.

  • 14 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q1 2019, up from 11 in Q4 2018.
  • Funds reported $1.09M of NeuroMetrix, Inc. Common Stock stock for Q1 2019, up 36% quarter-over-quarter.
  • 5 funds opened new NeuroMetrix, Inc. Common Stock positions in Q1 2019 and 2 closed out, a net change of +3 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q1 2019 was Renaissance Technologies, an estimated $86.6K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q1 2019 was Sabby Management, an estimated $370K sold.

Based on aggregated 13F filings for Q1 2019.